logo

For the Inventor, By the Inventor

Seoul, South Korea

Sang-Nae Cho

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Other. Active years: 2004-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sang-Nae Cho. Retrieved from https://idiyas.com/inventor/sang-nae-cho

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Yangchon-ku, Seoul KR (2004)
  • Banglee-dong, Songpa-ku, Seoul, KR (2005)

Company Filing History:

goldMedal2 out of 834,513 
Other
 patents

Years Active: 2004-2005

Loading Chart...
2 patents (USPTO):Explore Patents
1. 6951718 - rpoB gene fragments and a method for the diagnosis and identification of Mycobacterium tuberculosis and non-tuberculosis Mycobacterial strains (2005-10-04),
2. 6815165 - METHOD FOR IDENTIFYING MYCOBACTERIUM TUBERCULOSIS AND MYCOBACTERIA OTHER THAN TUBERCULOSIS, TOGETHER WITH DETECTING RESISTANCE TO AN ANTITUBERCULOSIS DRUG OF MYCOBACTERIA OBTAINED BY MUTATION OF RPOB GENE (2004-11-09),

Title: Innovations by Sang-Nae Cho

Introduction

Sang-Nae Cho is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of microbiology, particularly in the diagnosis and identification of Mycobacterium tuberculosis and non-tuberculosis Mycobacterial strains. With a total of 2 patents, his work has implications for public health and disease management.

Latest Patents

Sang-Nae Cho's latest patents include innovative methods related to rpoB gene fragments. One of his inventions focuses on a method for the diagnosis and identification of Mycobacterium tuberculosis and non-tuberculosis Mycobacterial strains. This invention utilizes rpoB gene fragments to enhance diagnostic accuracy. Another significant patent provides a method for identifying Mycobacterium tuberculosis and other Mycobacteria, along with determining drug susceptibility based on mutations in the rpoB gene. These advancements are crucial for improving treatment strategies for tuberculosis and related infections.

Career Highlights

Throughout his career, Sang-Nae Cho has demonstrated a commitment to advancing medical science through his research and inventions. His work has been instrumental in developing diagnostic tools that can lead to better patient outcomes.

Collaborations

Sang-Nae Cho has collaborated with notable colleagues, including Gill-Han Bai and Sang-Jae Kim. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Sang-Nae Cho's contributions to the field of microbiology through his patents reflect his dedication to improving healthcare solutions. His innovative methods for diagnosing and identifying Mycobacterium strains are vital for addressing public health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…